These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15803096)

  • 1. [Optimizing current drugs].
    Blay JY
    Ann Pharm Fr; 2005 Jan; 63(1):17-24. PubMed ID: 15803096
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib (Gleevec) as a paradigm of targeted cancer therapies.
    Druker B
    Keio J Med; 2010; 59(1):1-3. PubMed ID: 20375651
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.
    Druker BJ
    J Hematother Stem Cell Res; 2001 Dec; 10(6):721-4. PubMed ID: 11798498
    [No Abstract]   [Full Text] [Related]  

  • 4. Gold standard or wrong standard?
    Oldham R; Dillman R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):271-2. PubMed ID: 15285873
    [No Abstract]   [Full Text] [Related]  

  • 5. STI571 revolution: can the newer targeted drugs measure up?
    Garber K
    J Natl Cancer Inst; 2001 Jul; 93(13):970-3. PubMed ID: 11438556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].
    Ray-Coquard I; Blay JY
    Bull Cancer; 2002 Jun; 89(6):567-9. PubMed ID: 12135855
    [No Abstract]   [Full Text] [Related]  

  • 7. A new era in cancer therapeutics?
    Westwell AD
    Drug Discov Today; 2003 Jan; 8(2):64-5. PubMed ID: 12565007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 9. A widening prospect: Imatinib and novel applications of targeted therapy.
    Rowinsky EK
    Semin Oncol; 2004 Apr; 31(2 Suppl 6):1-3. PubMed ID: 15175997
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib mesylate for melanoma: will a new target be revealed?
    Grossman D
    J Invest Dermatol; 2004 Dec; 123(6):xi-xiii. PubMed ID: 15610499
    [No Abstract]   [Full Text] [Related]  

  • 11. Part I: Milestones in personalised medicine--imatinib.
    Gambacorti-Passerini C
    Lancet Oncol; 2008 Jun; 9(6):600. PubMed ID: 18510992
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting cancers with tyrosine kinase inhibitors: lessons learned from chronic myeloid leukaemia.
    Mughal TI; Goldman JM
    Clin Med (Lond); 2006; 6(6):526-8. PubMed ID: 17228548
    [No Abstract]   [Full Text] [Related]  

  • 13. Images in pathology. Morphologic features of response to Gleevec (Imatinib) treatment of GIST.
    Colecchia M; Diment J
    Int J Surg Pathol; 2003 Apr; 11(2):119. PubMed ID: 12754630
    [No Abstract]   [Full Text] [Related]  

  • 14. Researchers optimistic about sea change in cancer treatment.
    Stephenson J
    JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
    [No Abstract]   [Full Text] [Related]  

  • 15. Phacilitate Cell and Gene Therapy Forum 2005. Cell and gene therapy: a corporate perspective. 24-26 January 2005, Washington, DC, USA.
    Salmons B
    IDrugs; 2005 Mar; 8(3):203-5. PubMed ID: 15772888
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
    Parmar KK; King RS
    Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges in oncology. Case 4. Response of metastatic gastrointestinal stromal tumor including CNS involvement to imatinib mesylate (STI-571).
    Brooks BJ; Bani JC; Fletcher CD; Demeteri GD
    J Clin Oncol; 2002 Feb; 20(3):870-2. PubMed ID: 11821475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic myelogenous leukemia by using imatinib].
    Jinnai I
    Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1819-24. PubMed ID: 16223141
    [No Abstract]   [Full Text] [Related]  

  • 19. Imatinib Changed Everything.
    Longo DL
    N Engl J Med; 2017 Mar; 376(10):982-983. PubMed ID: 28273011
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives on the development of imatinib and the future of cancer research.
    Druker BJ
    Nat Med; 2009 Oct; 15(10):1149-52. PubMed ID: 19812576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.